EMEA Grants Orphan Drug Status to Active Biotech’s Cancer Treatment Anyara

Active Biotech AB announced that Anyara has been granted Orphan Drug Status by the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA).
Ad-Hoc-News